Tae-You Kim Selected Research

Tae-You Kim Research Topics

Disease

141	Neoplasms (Cancer) 01/2024 - 01/2003
53	Stomach Neoplasms (Stomach Cancer) 01/2019 - 01/2003
51	Breast Neoplasms (Breast Cancer) 07/2023 - 03/2004
43	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 10/2005
30	Neoplasm Metastasis (Metastasis) 05/2023 - 04/2004
26	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 03/2005
22	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2014 - 06/2002
14	Adenocarcinoma 01/2016 - 11/2004
13	Colonic Neoplasms (Colon Cancer) 01/2023 - 07/2010
11	Rectal Neoplasms (Rectal Cancer) 01/2023 - 12/2013
11	Biliary Tract Neoplasms (Biliary Tract Cancer) 10/2017 - 01/2008
10	Microsatellite Instability 01/2021 - 07/2011
9	Carcinoma (Carcinomatosis) 10/2010 - 02/2004
8	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 10/2011
8	Carcinogenesis 12/2017 - 04/2004
7	Disease Progression 01/2021 - 01/2008
7	Triple Negative Breast Neoplasms 07/2017 - 11/2007
6	Nausea 01/2019 - 02/2009
6	Lung Neoplasms (Lung Cancer) 01/2015 - 11/2007
6	Hypoxia (Hypoxemia) 07/2013 - 02/2002
5	Infections 02/2023 - 05/2002
5	Vomiting 01/2019 - 12/2004
4	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2018 - 01/2009
3	Hepatitis 02/2023 - 07/2014
3	Residual Neoplasm 01/2023 - 11/2014
3	Fatigue 01/2021 - 10/2014
3	Margins of Excision 07/2019 - 12/2013
3	Neutropenia 01/2019 - 10/2014
3	Obesity 10/2017 - 12/2012
3	Thrombocytopenia (Thrombopenia) 07/2016 - 12/2013
3	Weight Loss (Weight Reduction) 04/2016 - 06/2002

Drug/Important Bio-Agent (IBA)

28	Fluorouracil (Carac)FDA LinkGeneric 12/2023 - 01/2003
21	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 11/2002
19	DNA (Deoxyribonucleic Acid)IBA 05/2023 - 04/2004
17	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2019 - 05/2008
16	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2011
16	Proteins (Proteins, Gene)FDA Link 09/2017 - 01/2003
16	ErbB Receptors (EGF Receptor)IBA 10/2015 - 01/2005
15	Sorafenib (BAY 43-9006)FDA Link 02/2023 - 04/2011
14	Trastuzumab (Herceptin)FDA Link 10/2019 - 01/2008
13	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015 - 12/2003
11	Gemcitabine FDA Link 10/2021 - 06/2006
11	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 01/2003
11	Tyrosine Kinase InhibitorsIBA 07/2018 - 11/2007
11	PlatinumIBA 01/2018 - 01/2005
10	Leucovorin (Folinic Acid)FDA Link 12/2023 - 05/2008
10	Lapatinib (GW572016)FDA Link 10/2019 - 03/2008
10	Histone Deacetylase InhibitorsIBA 12/2018 - 03/2004
10	Gefitinib (Iressa)FDA Link 02/2012 - 01/2005
9	Irinotecan (Camptosar)FDA LinkGeneric 12/2023 - 09/2008
9	human ERBB2 proteinIBA 12/2013 - 10/2008
8	Hormones (Hormone)IBA 01/2020 - 02/2010
8	Estrogen ReceptorsIBA 12/2015 - 03/2004
8	Docetaxel (Taxotere)FDA Link 01/2015 - 07/2005
7	Cell-Free Nucleic AcidsIBA 02/2024 - 01/2020
7	Bevacizumab (Avastin)FDA Link 01/2024 - 02/2013
7	Calcibiotic Root Canal SealerIBA 01/2021 - 07/2011
7	Capecitabine (Xeloda)FDA Link 03/2019 - 01/2011
7	MethyltransferasesIBA 04/2016 - 04/2004
7	Histones (Histone)IBA 07/2012 - 08/2005
6	Cetuximab (Erbitux)FDA Link 08/2023 - 03/2008
6	Circulating Tumor DNAIBA 08/2023 - 01/2020
6	regorafenibIBA 07/2023 - 01/2015
6	taxaneIBA 12/2017 - 06/2008
5	atezolizumabIBA 01/2024 - 01/2020
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 09/2009
5	NivolumabIBA 11/2020 - 06/2017
5	Messenger RNA (mRNA)IBA 10/2019 - 02/2002
5	ChromatinIBA 12/2017 - 07/2013
5	Thymidylate SynthaseIBA 07/2011 - 12/2006
5	Histone Deacetylases (Histone Deacetylase)IBA 08/2010 - 12/2003
5	Transforming Growth Factor beta1 (TGF beta 1)IBA 08/2005 - 02/2004
4	thiamine triphosphorate (TTP)IBA 01/2018 - 08/2010
4	Methotrexate (Mexate)FDA LinkGeneric 12/2017 - 12/2003
4	AnthracyclinesIBA 12/2017 - 08/2005
4	CytokinesIBA 03/2017 - 12/2007
4	hydrogen sulfite (bisulfite)IBA 04/2016 - 04/2004
4	Epidermal Growth Factor (EGF)IBA 11/2013 - 11/2006
3	olaparibIBA 07/2023 - 06/2013
3	RamucirumabIBA 11/2021 - 10/2014
3	Monoclonal AntibodiesIBA 01/2021 - 08/2012
3	B7-H1 AntigenIBA 01/2021 - 11/2016
3	Carcinoembryonic AntigenIBA 01/2020 - 07/2017
3	MucinsIBA 07/2019 - 09/2015
3	RNA (Ribonucleic Acid)IBA 01/2019 - 10/2007
3	HM781-36BIBA 07/2018 - 03/2011
3	CohesinsIBA 12/2017 - 01/2016
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2017 - 04/2007
3	Phenobarbital (Luminal)FDA Link 01/2016 - 12/2013
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2016 - 12/2008
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2016 - 05/2011

Therapy/Procedure

88	Drug Therapy (Chemotherapy) 08/2023 - 11/2002
48	Therapeutics 01/2024 - 12/2003
23	Neoadjuvant Therapy 01/2023 - 11/2004
19	Adjuvant Chemotherapy 01/2023 - 12/2004
19	Radiotherapy 04/2022 - 06/2002
15	Chemoradiotherapy 02/2024 - 06/2002
12	Adjuvant Chemoradiotherapy 04/2017 - 02/2009
12	Combination Drug Therapy (Combination Chemotherapy) 09/2014 - 01/2003
3	Adjuvant Radiotherapy 01/2016 - 07/2010